Century Therapeutics, Inc. (IPSC)

NASDAQ: IPSC · Real-Time Price · USD

1.950

+0.030 (1.56%)

At close: Aug 17, 2026, 4:00 PM EDT

1.980

+0.030 (1.54%)

After-hours: Aug 17, 2026, 6:46 PM EDT

Century Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	-	109.16	6.59	2.24	5.2	-
Revenue Growth	-	1556.76%	194.81%	-57.01%	-	-
Cost of Revenue	78.93	95.67	107.24	92.71	97.17	75.65
Gross Profit	-78.93	13.5	-100.66	-90.48	-91.97	-75.65
Selling, General & Admin	28.59	28.54	34.51	34.71	31.86	19.24
Operating Expenses	28.59	28.54	34.51	34.71	31.86	19.24
Operating Income	-107.52	-15.04	-135.17	-125.18	-123.83	-94.88
Interest Expense	-	-	-	-0.54	-1.43	-1.28
Interest & Investment Income	6.92	7.35	13.01	12.68	4.42	0.38
Other Non Operating Income (Expenses)	0.22	0.28	0.35	-0.38	-	-
EBT Excluding Unusual Items	-100.39	-7.42	-121.81	-113.43	-120.84	-95.78
Impairment of Goodwill	-	-	-4.33	-	-	-
Asset Writedown	-6.76	-6.76	-	-16.37	-	-
Other Unusual Items	-2.71	4.53	1.36	-	-	-
Pretax Income	-109.86	-9.65	-124.78	-134.79	-130.84	-95.78
Income Tax Expense	-0.07	-0.07	1.79	1.88	0.09	0.04
Net Income	-109.79	-9.58	-126.57	-136.67	-130.93	-95.82
Net Income to Common	-109.79	-9.58	-126.57	-136.67	-130.93	-95.82
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	143	87	79	59	58	32
Shares Outstanding (Diluted)	143	87	79	59	58	32
Shares Change	67.40%	10.05%	32.60%	2.70%	78.30%	332.95%
EPS (Basic)	-0.77	-0.11	-1.61	-2.30	-2.27	-2.96
EPS (Diluted)	-0.77	-0.11	-1.61	-2.30	-2.27	-2.96
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-88.09	-104.72	-110.29	-102.08	-16.55	-133.97
Free Cash Flow Per Share	-0.61	-1.21	-1.40	-1.72	-0.29	-4.14
Gross Margin	-	12.36%	-	-	-	-
Operating Margin	-	-13.78%	-2051.39%	-5600.94%	-2381.82%	-
Profit Margin	-	-8.78%	-1920.87%	-6115.12%	-2518.41%	-
Free Cash Flow Margin	-	-95.93%	-1673.84%	-4567.52%	-318.37%	-
EBITDA	-95.22	-1.94	-121.86	-112.14	-115.39	-91.14
EBITDA Margin	-	-1.78%	-	-	-	-
D&A For EBITDA	12.3	13.1	13.3	13.04	8.44	3.75
EBIT	-107.52	-15.04	-135.17	-125.18	-123.83	-94.88
EBIT Margin	-	-13.78%	-	-	-	-

SEC Filings: 10-K · 10-Q